Trial intelligence / Profile preview

Vitamin D Supplementation in Chronic Stable Heart Failure

NCT01292720Phase 3Completed

Sponsor
Medical University of Graz
Start
Apr 2011
Primary completion
Oct 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in heart failure (HF) comparing Placebo with Vitamin D (2 arms). Primary endpoint: N-terminal pro b-type natriuretic peptide at 6 months. Started Apr 2011; status: completed.

02

Drugs

vitamin d
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01292720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01292720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call